摘要
目的:探讨三丙烯微球联合碘化油治疗原发性肝细胞癌的疗效价值。方法:入组56例原发性肝细胞癌患者,分为试验组(n=22)与对照组(n=34),试验组行三丙烯微球联合碘化油治疗方案,对照组行传统碘化油治疗方案,比较两组间疗效与出现各种不良反应的差异。结果:试验组与对照组在疗效上无统计学差异,试验组不良反应肝区重度疼痛与呕吐症状病例数试验组少于对照组,而发热病例数两组间无统计学差异,试验组不良反应持续时间短于对照组。结论:三丙烯微球联合碘化油治疗原发性肝细胞癌的疗效与传统碘化油治疗方案相当,但不良反应明显减轻,值得临床推广。
Objective To explore the effects of embosphere microspheres combined with lipiodol on primary hepatocellular carcinoma. Methods Fifty-six patient with primary hepatocellular carcinoma were divided into experiment group （n = 22） and control group （n = 34）. Patients in experiment group received embosphere microspheres combined with lipiodol treatment and those in control group received lipiodol treatment. The effieacies and side effects of the two groups were compared. Results There was no statistical difference in efficacies between the two groups. The side effects such as serious liver pain and disgorging in experiment group were fewer than those in control group ; there was no statistical difference in the number of cases with fever between the two groups ; the duration of side effects in experiment group was shorter than that in control group. Conclusion The efficacy of embosphere microspheres combined with lipiodol treatment was similar to that of lipiodol treatment, but with fewer side effects.
出处
《实用医学杂志》
CAS
北大核心
2014年第2期290-292,共3页
The Journal of Practical Medicine
基金
广东省科技计划项目(编号:2009B030801027)
广东省自然科学基金(编号:7001663)
关键词
原发性肝细胞癌
肝动脉内化疗栓塞术
三丙烯微球
碘化油
Primary hepatocellular carcinoma
Transcatheter arterial chemoembolization
Embosphere microspheres
Lipiodol
